Nationalität
USA

Geburtsjahr
1966

  • Massachusetts Institute of Technology, M.Sc. in Management; M.Sc.in Chemieingenieurwesen (Biochemical Processing)

  • University of Texas, Austin, Texas B. S. in Chemieingenieurwesen

1989
Prozessingenieur Forschung & Entwicklung, Ethyl Corporation, Den Haag, Niederlande

1990
Line Supervisor, Ethyl Corporation, Brüssel, Belgien

1995
Marketing Manager, Display Products Venture, Raychem Corporation, San Francisco Bay Area, USA

1997
Business Planning Manager, Biogen, Cambridge, Massachusetts, USA

1999
Managing Director, Vereinigtes Königreich und Irland, Biogen, London, UK

2001
Vice President of Finance, Business Planning, Biogen Idec., Cambridge, Massachusetts, USA

2004
Vice President und General Manager, Geschäftseinheit Neurologie, Biogen Idec., USA

2006
Senior Vice President, Geschäftseinheit Immunologie und Ophthalmologie, Genentech, USA

2010
Senior Vice President, Geschäftseinheit BioOnkology, Genentech, USA

2013
Head of Global Product Strategy / Chief Marketing Officer, Roche Pharmaceuticals, Basel, Schweiz

2016
Leiter North American Operations Genentech, USA

2017-2018
Chief Executive Officer, Genentech, USA

2019-heute
CEO Roche Pharmaceutical

2019-heute
Chugai Pharmaceuticals

  • FHI (Flatiron Health, Inc.)

  • FMI (Foundation Medicine, Inc.)

  • GNE (Genentech, Inc.)

  • Spark Therapeutics

  • 2017-2018: BIO (Biotechnology Innovation Organization)

  • 2019-2020: PhRMA (Pharmaceutical Research and Manufacturers of America)

  • Januar 2021-heute: European Federation of Pharmaceuticals Industries and Associations

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.